Lactulose Heumann

Lactulose, the active ingredient in Lactulose Heumann, is an osmotic laxative presented as an oral solution for oral use. It is employed to treat constipation and to reduce ammonia levels in patients with hepatic encephalopathy, particularly in adult patients requiring medical management of these conditions.

GNH USA supplies Lactulose Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for healthcare providers across multiple regions.

Lactulose acts as an osmotic agent to manage conditions related to bowel motility and ammonia accumulation. - Constipation: softens stool and promotes bowel movements by drawing water into the intestinal lumen. - Hepatic encephalopathy: lowers blood ammonia levels, helping to improve neurological function in patients with liver disease. - Chronic constipation management: provides long‑term relief for patients requiring ongoing laxative therapy.

Lactulose may cause a range of adverse reactions, most of which are related to its osmotic activity in the gut.

Common Side Effects: - Bloating: sensation of abdominal fullness. - Flatulence: increased intestinal gas. - Abdominal cramps: mild to moderate pain. - Diarrhea: loose stools, especially at higher doses. - Nausea: feeling of queasiness. - Electrolyte imbalance: mild changes in sodium or potassium levels.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss leading to low blood pressure. - Marked electrolyte disturbances: significant hyponatremia or hypokalemia. - Allergic reactions: rash, itching, or swelling. - Acute abdominal pain: severe, persistent pain requiring medical attention. - Rectal bleeding: uncommon but may indicate mucosal injury.

Before prescribing Lactulose, clinicians should consider several safety aspects. - Renal function assessment: monitor patients with impaired kidney function for fluid and electrolyte changes. - Electrolyte monitoring: check serum sodium and potassium during prolonged therapy. - Diabetes caution: the sugar content may affect blood glucose; monitor glycemic control. - Intestinal obstruction avoidance: do not use in patients with known bowel blockage. - Hepatic impairment adjustment: dose may need modification in severe liver disease. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Lactulose can interact with other medications, altering its efficacy or safety.

Major Interactions (Avoid): - Antacids containing magnesium: may increase laxative effect and cause electrolyte imbalance. - Loop diuretics: combined use can exacerbate dehydration and electrolyte loss. - Insulin or oral hypoglycemics: sugar content of Lactulose may affect glucose control.

Moderate Interactions (Monitor Closely): - Broad‑spectrum antibiotics: may alter gut flora, affecting Lactulose metabolism. - Other laxatives: additive effect may lead to excessive diarrhea. - Oral rehydration solutions: concurrent use may require electrolyte monitoring.